Since CTLA-4 expression is transiently inducible during T and B activation [27, 28] and it is considered to be an activation marker, the higher expression of CTLA-4 in CLL cells may reflect the systemic activation status in the periphery in CLL patients. This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.